title: Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure.
abstract: BACKGROUND
  Current research focuses on cancer therapy, diagnostics and imaging, although many challenges still need to be solved. However, for the application of gold nanoparticles (GNPs) in therapy and diagnostics it is necessary to know the bioaccumulation and local or systemic toxicity associated to them. The aim of the present study was to investigate the effects of intraperitoneal administration of GNPs on the histological alterations of the heart tissue of rats in an attempt to cover and understand the toxicity and the potential role of GNPs in the therapeutic and diagnostic applications.
  
  
  METHODS
  Animals were randomly divided into 3 GNPs-treated rats groups and one control group (CG). The 10, 20 and 50 nm GNPs were administered intraperitonealy at the rate of 3 or 7 days as follows: Group 1: received infusion of 100 μl GNPs of size 10 nm for 3 or 7 days; Group 2: received infusion of 100 μl GNPs of size 20 nm for 3 or 7 days; Group 3: received infusion of 100 μl GNPs of size 50 nm for 3 or 7 days.
  
  
  METHODS
  received no GNPs.
  
  
  RESULTS
  In comparison with the respective control rats, GNPs-treated rat received 100 μl of 10 and 20 nm particles for 3 days or 7 days demonstrating congested heart muscle with prominent dilated blood vessels, scattered and extravasations of red blood cells, focus of muscle hyalinosis, disturbed muscle fascicles, dense prominent focus of inflammatory cells infiltrate by small lymphocytes and few plasma cells while GNPs-treated rat received 100 μl of 50 nm particles for 3 or 7 days demonstrating benign normal looking heart muscle with normal muscle direction and fascicles, and very few scattered small lymphocytes.
  
  
  CONCLUSIONS
  The histological alterations induced by intraperitoneal administration of GNPs were size-dependent with smaller ones induced more affects and related with time exposure of GNPs. This study suggests that interaction of GNPs with proteins and various cell types might be evaluated as part of the toxicological assessment in addition to further experiments related to tissues antioxidant enzymes, oxidative parameters, lipid peroxidation, production of free radicals and/or ROS and cytokine, histomorphologcal and ultrastrucural will be performed to cover and understand the toxicity and the potential use of GNPs as therapeutic and diagnostic tool.
authors.affiliation: Department of Physics and Astronomy, College of Science, King Saud University, Saudi Arabia. abdelhalimmak@yahoo.com
authors.forename: Mohamed Anwar K
authors.initials: MA
authors.lastname: Abdelhalim
mesh_terms: D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology; D006046:Gold / Q000737:chemistry / Q000633:toxicity*; D006335:Heart Injuries / Q000139:chemically induced*; D008297:Male; D053768:Metal Nanoparticles / Q000737:chemistry / Q000633:toxicity*; D009206:Myocardium / Q000473:pathology; D010316:Particle Size; D011897:Random Allocation; D051381:Rats; D011921:Rats, Inbred WKY
chemical_list: D006046:Gold
references.citation: Toxicol Appl Pharmacol. 2001 Sep 15;175(3):191-9
references.pmid: 11559017
references.citation: Biochem Biophys Res Commun. 2010 Mar 19;393(4):649-55
references.pmid: 20153731
references.citation: Science. 2006 Feb 3;311(5761):622-7
references.pmid: 16456071
references.citation: Small. 2009 Sep;5(18):2067-76
references.pmid: 19642089
references.citation: J Am Chem Soc. 2009 Jan 14;131(1):40-1
references.pmid: 19072650
references.citation: Oncol Rep. 2005 Jun;13(6):1003-7
references.pmid: 15870914
references.citation: Lipids Health Dis. 2011 Aug 05;10:133
references.pmid: 21819574
references.citation: Nanotechnology. 2008 Jun 11;19(23):235104
references.pmid: 21825779
references.citation: J Toxicol Environ Health A. 2002 Oct 25;65(20):1513-30
references.pmid: 12396866
references.citation: J Toxicol Environ Health A. 2002 Oct 25;65(20):1531-43
references.pmid: 12396867
references.citation: Aquat Toxicol. 2010 Oct 15;100(2):178-86
references.pmid: 20382436
references.citation: J Toxicol Environ Health A. 2003 Oct 24;66(20):1909-26
references.pmid: 14514433
references.citation: Occup Environ Med. 2004 Sep;61(9):727-8
references.pmid: 15317911
references.citation: J Control Release. 2005 Mar 2;103(1):235-43
references.pmid: 15710514
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 May;290(5):G852-8
references.pmid: 16603729
references.citation: Lipids Health Dis. 2011 Sep 21;10:163
references.pmid: 21936889
references.citation: Eur Respir J Suppl. 2003 May;40:47s-51s
references.pmid: 12762574
references.citation: Ann Ist Super Sanita. 2003;39(3):405-10
references.pmid: 15098562
references.citation: J Nanosci Nanotechnol. 2004 May;4(5):521-31
references.pmid: 15503438
references.citation: Langmuir. 2006 Jan 3;22(1):2-5
references.pmid: 16378388
references.citation: Curr Mol Med. 2006 Sep;6(6):651-63
references.pmid: 17022735
references.citation: J Nanobiotechnology. 2010 Jul 14;8:16
references.pmid: 20630072
references.citation: Biotechnol Prog. 2005 Mar-Apr;21(2):532-7
references.pmid: 15801794
references.citation: Toxicol In Vitro. 2005 Oct;19(7):975-83
references.pmid: 16125895
references.citation: Occup Environ Med. 2001 Mar;58(3):211-6, 199
references.pmid: 11171936
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):279-84
references.pmid: 15630089
references.citation: Biomaterials. 2003 Jan;24(1):55-63
references.pmid: 12417178
references.citation: Chembiochem. 2004 Mar 5;5(3):275-9
references.pmid: 14997519
references.citation: Nano Lett. 2008 Apr;8(4):1229-36
references.pmid: 18318505
references.citation: Lipids Health Dis. 2011 Sep 22;10:166
references.pmid: 21939512
references.citation: Small. 2007 Nov;3(11):1941-9
references.pmid: 17963284
references.citation: Small. 2005 Mar;1(3):325-7
references.pmid: 17193451
references.citation: Environ Health Perspect. 2005 Jul;113(7):823-39
references.pmid: 16002369
references.citation: Bull Mem Acad R Med Belg. 2004;159(5-6):358-66
references.pmid: 15693545
references.citation: Mol Microbiol. 2006 Mar;59(6):1744-53
references.pmid: 16553880
references.citation: Lipids Health Dis. 2011 Aug 22;10:147
references.pmid: 21859444
references.citation: Med Hypotheses. 2005;64(4):818-25
references.pmid: 15694703
references.citation: J Toxicol Environ Health A. 2003 Jun 27;66(12):1087-112
references.pmid: 12854532
references.citation: Curr Opin Pulm Med. 2001 Jan;7(1):20-6
references.pmid: 11140402